BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37999644)

  • 21. ADAP1 limits neonatal cardiomyocyte hypertrophy by reducing integrin cell surface expression.
    Giguère H; Dumont AA; Berthiaume J; Oliveira V; Laberge G; Auger-Messier M
    Sci Rep; 2018 Sep; 8(1):13605. PubMed ID: 30206251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IQGAP1 regulates ERK1/2 and AKT signalling in the heart and sustains functional remodelling upon pressure overload.
    Sbroggiò M; Carnevale D; Bertero A; Cifelli G; De Blasio E; Mascio G; Hirsch E; Bahou WF; Turco E; Silengo L; Brancaccio M; Lembo G; Tarone G
    Cardiovasc Res; 2011 Aug; 91(3):456-64. PubMed ID: 21493702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The action of nitric oxide to enhance cell survival in chick cardiomyocytes is mediated through a cGMP and ERK1/2 pathway while p38 mitogen-activated protein kinase-dependent pathways do not alter cell death.
    Rabkin SW; Tsang MY
    Exp Physiol; 2008 Jul; 93(7):834-42. PubMed ID: 18344257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calreticulin inhibits the MEK1,2-ERK1,2 pathway in alpha 1-adrenergic receptor/Gh-stimulated hypertrophy of neonatal rat cardiomyocytes.
    Lee KH; Lee N; Lim S; Jung H; Ko YG; Park HY; Jang Y; Lee H; Hwang KC
    J Steroid Biochem Mol Biol; 2003 Jan; 84(1):101-7. PubMed ID: 12648529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different contributions of STAT3, ERK1/2, and PI3-K signaling to cardiomyocyte hypertrophy by cardiotrophin-1.
    Tian ZJ; Cui W; Li YJ; Hao YM; Du J; Liu F; Zhang H; Zu XG; Liu SY; Chen L; An W
    Acta Pharmacol Sin; 2004 Sep; 25(9):1157-64. PubMed ID: 15339391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes-Induced Cardiomyocyte Passive Stiffening Is Caused by Impaired Insulin-Dependent Titin Modification and Can Be Modulated by Neuregulin-1.
    Hopf AE; Andresen C; Kötter S; Isić M; Ulrich K; Sahin S; Bongardt S; Röll W; Drove F; Scheerer N; Vandekerckhove L; De Keulenaer GW; Hamdani N; Linke WA; Krüger M
    Circ Res; 2018 Jul; 123(3):342-355. PubMed ID: 29760016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deficiency in nebulin repeats of sarcomeric nebulette is detrimental for cardiomyocyte tolerance to exercise and biomechanical stress.
    Vejandla RM; Orgil BO; Alberson NR; Li N; Munkhsaikhan U; Khuchua Z; Martherus R; Azeloglu EU; Xu F; Lu L; Towbin JA; Purevjav E
    Am J Physiol Heart Circ Physiol; 2021 May; 320(5):H2130-H2146. PubMed ID: 33861145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C3G overexpression promotes the survival of rat-derived H9C2 cardiomyocytes by p-ERK1/2.
    Zhang X; Li G; Zhang L; Yang D; Zhang Z; Yan A; Linghu H
    Cell Biol Int; 2013 Oct; 37(10):1106-13. PubMed ID: 23686869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate.
    Frias MA; James RW; Gerber-Wicht C; Lang U
    Cardiovasc Res; 2009 May; 82(2):313-23. PubMed ID: 19151362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway.
    Meng R; Pei Z; Zhang A; Zhou Y; Cai X; Chen B; Liu G; Mai W; Wei J; Dong Y
    Arch Biochem Biophys; 2011 Jul; 511(1-2):1-7. PubMed ID: 21530483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ERK1/2 signaling dominates over RhoA signaling in regulating early changes in RNA expression induced by endothelin-1 in neonatal rat cardiomyocytes.
    Marshall AK; Barrett OP; Cullingford TE; Shanmugasundram A; Sugden PH; Clerk A
    PLoS One; 2010 Apr; 5(4):e10027. PubMed ID: 20368814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-talk between MEK1/2-ERK1/2 signaling and G protein-couple signaling in synoviocytes of collagen-induced arthritis rats.
    Zhang LL; Wei W; Wang QT; Chen JY; Chen Y
    Chin Med J (Engl); 2008 Nov; 121(22):2278-83. PubMed ID: 19080332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signal-dependent repression of DUSP5 by class I HDACs controls nuclear ERK activity and cardiomyocyte hypertrophy.
    Ferguson BS; Harrison BC; Jeong MY; Reid BG; Wempe MF; Wagner FF; Holson EB; McKinsey TA
    Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9806-11. PubMed ID: 23720316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ablation of p21-activated kinase-1 in mice promotes isoproterenol-induced cardiac hypertrophy in association with activation of Erk1/2 and inhibition of protein phosphatase 2A.
    Taglieri DM; Monasky MM; Knezevic I; Sheehan KA; Lei M; Wang X; Chernoff J; Wolska BM; Ke Y; Solaro RJ
    J Mol Cell Cardiol; 2011 Dec; 51(6):988-96. PubMed ID: 21971074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FasL expression in cardiomyocytes activates the ERK1/2 pathway, leading to dilated cardiomyopathy and advanced heart failure.
    Huby AC; Turdi S; James J; Towbin JA; Purevjav E
    Clin Sci (Lond); 2016 Feb; 130(4):289-99. PubMed ID: 26566650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.
    Aoki H; Richmond M; Izumo S; Sadoshima J
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):275-84. PubMed ID: 10727428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SOCS-1 inhibits TNF-alpha-induced cardiomyocyte apoptosis via ERK1/2 pathway activation.
    Yan L; Tang Q; Shen D; Peng S; Zheng Q; Guo H; Jiang M; Deng W
    Inflammation; 2008 Jun; 31(3):180-8. PubMed ID: 18330685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. β-Adrenergic stimulation activates protein kinase Cε and induces extracellular signal-regulated kinase phosphorylation and cardiomyocyte hypertrophy.
    Li L; Cai H; Liu H; Guo T
    Mol Med Rep; 2015 Jun; 11(6):4373-80. PubMed ID: 25672459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. JNK1/c-fos inhibits cardiomyocyte TNF-alpha expression via a negative crosstalk with ERK and p38 MAPK in endotoxaemia.
    Peng T; Zhang T; Lu X; Feng Q
    Cardiovasc Res; 2009 Mar; 81(4):733-41. PubMed ID: 19043087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MEK1 inhibits cardiac PPARα activity by direct interaction and prevents its nuclear localization.
    el Azzouzi H; Leptidis S; Bourajjaj M; van Bilsen M; da Costa Martins PA; De Windt LJ
    PLoS One; 2012; 7(6):e36799. PubMed ID: 22723831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.